(Q43921759)

28 November 2017

title

Behavioural and biochemical studies of citalopram and WAY 100635 in rat chronic mild stress model (English)

1 reference

Lucyna Antkiewicz-Michaluk

28 November 2017

author

series ordinal

object named as

Lucyna Antkiewicz-Michaluk

1 reference

28 November 2017

Mariusz Papp

1 reference

28 November 2017

Irena Nalepa

1 reference

28 November 2017

Connie Sánchez

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

Pharmacology, Biochemistry and Behavior

28 November 2017

published in

1 reference

28 November 2017

1 reference

28 November 2017

issue

1-2

1 reference

28 November 2017

page(s)

465-474

1 reference

Patients With Severe Depression May Benefit From Buspirone Augmentation of Selective Serotonin Reuptake Inhibitors

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Partial 5-HT1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Development of β-adrenergic receptor subsensitivity by antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Current advances and trends in the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Selective serotonin reuptake inhibitors plus pindolol. The REEP

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Combining pindolol and paroxetine in an animal model of chronic antidepressant action--can early onset of action be detected?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Biochemical evidence for the regulation of central noradrenergic activity by 5-HT1A and 5-HT2 receptors: microdialysis studies in the awake and anaesthetized rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Weak antidepressant response after buspirone augmentation of serotonin reuptake inhibitors in refractory severe depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its a

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Autoreceptor Antagonists Enhance the Effect of the Reuptake Inhibitor Citalopram on Extracellular 5-HT: this Effect Persists After Repeated Citalopram Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Influence of 5-HT1A receptors on central noradrenergic activity: microdialysis studies using (+/-)-MDL 73005EF and its enantiomers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Effect of a selective 5-hydroxytryptamine reuptake inhibitor on brain extracellular noradrenaline: microdialysis studies using paroxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Pindolol occupancy of 5-HT(1A) receptors measured in vivo using small animal positron emission tomography with carbon-11 labeled WAY 100635

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

W ay 100635-induced Augmentation of the 5-HT-elevating Action of Citalopram: Relative Importance of the Dose of the 5-HT 1A (Auto)receptor Blocker Versus that of the 5-HT Reuptake Inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Regulation of beta 1-adrenergic receptor mRNA and ligand binding by antidepressant treatments and norepinephrine depletion in rat frontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Evidence from microdialysis and synaptosomal studies of rat cortex for noradrenaline uptake sites with different sensitivities to SSRIs

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Biochemical effects and drug levels in rats after long-term treatment with the specific 5-HT-uptake inhibitor, citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Where are we going with SSRIs?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Effect of 5-HT1A Receptor Antagonists on Citalopram-induced Increase in Extracellular Serotonin in the Frontal Cortex, Striatum and Dorsal Hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Effect of long-term administration of antidepressant drugs on the 5-HT3 receptors that enhance the electrically evoked release of [3H]noradrenaline in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Dopaminergic mechanism of imipramine action in an animal model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Involvement of protein kinase C in the mechanism of in vitro effects of imipramine on generation of second messengers by noradrenaline in cerebral cortical slices of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Enhancement of the responsiveness of cortical adrenergic receptors by chronic administration of the 5-hydroxytryptamine uptake inhibitor citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Agonist and antagonist actions of (-)pindolol at recombinant, human serotonin1A (5-HT1A) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Up-regulation of beta 1-adrenergic receptors in rat brain after chronic citalopram and fluoxetine treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Reversal by imipramine of beta-adrenoceptor up-regulation induced in a chronic mild stress model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Effects of imipramine on serotonergic and beta-adrenergic receptor binding in a realistic animal model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Chronic treatment with citalopram induces noradrenaline receptor hypoactivity. A microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

In vivo serotonin release and learned helplessness

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

The effect of 5-HT1A receptor ligands in a chronic mild stress model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

The role of 5-HT1A and 5-HT1B receptors in antidepressant drug actions in the mouse forced swimming test

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

A highly sensitive adenylate cyclase assay

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

The selective sigma2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

A radioisotopic method for measuring the formation of adenosine 3',5'-cyclic monophosphate in incubated slices of brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

5-HT(1A) agonist potential of pindolol: electrophysiologic studies in the dorsal raphe nucleus and hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Antidepressants: past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900778-X

7 January 2021

10.1016/S0091-3057(01)00778-X

Identifiers

DOI

1 reference

28 November 2017

1 reference